July 2014 Issue Table Of Contents

From The Editor

• Finding Disruptive Innovators In Clinical Trials

Feature Articles

• Millennium Carries On With The Takeda Oncology Expansion
• J&J’s Approach To Capturing Disruptive Innovation In Clinical Trials
• Life Science Industry Partnerships With Patient Foundations: The Best Practices

Capitol Perspectives

• New Medicare Data and Litigation Provide Fresh Reasons For Congress To Reform 304B

Companies To Watch

• Microbiome: Second Genome Is Finding Disease Mechanisms, Biomarkers, And Therapeutics

Outsourcing Insights

• Outsourcing Trends In Small Molecule API Manufacturing

Bio Innovation notes

Best Practices In Standardizing Single-Use Device Connectivity

Inside The Industry

• The Falsified medicines Directive – What Does It Really Mean?
• Merck’s Continuous Process Improvement
• The Evolving Role Of Drug Mechanism Of Action In Drug Discovery And Development
• eTMFs: Moving From Electronic Filing Cabinet To Strategic Asset
• Global Drug Discovery Outsourcing Market Gaining Momentum

Industry Leader

• Best Practices For Designing Cell-Based cGMP Facilities

Leadership Lessons

• Defining Presence As A Leadership Behavior

Ask The Board

• Ask The Board